In particular, it will be crucial in future studies to validate many of these findings (e.g. TP53 expression and DNA promoter methylation, let-7a levels) in purified CD4+ T cell populations from PTSD and control samples, as opposed to whole circulating PBMC populations, which consists of a variety of different immune cell types. This evidence concerns the gene TP53 and post-traumatic stress disorder.